This Article  • PDF of this Correction  • Original article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 2005;294:3092.

Author Contribution Omissions: In the Original Contribution entitled "High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction: The IDEAL Study: A Randomized Controlled Trial" published in the November 16, 2005, issue of JAMA (2005;294:2437-2445), several contributions were omitted for the author Anders G. Olsson, MD, PhD. In addition to his contributions listed in the article, Dr Olsson contributed to the study concept and design, acquisition of data, drafting of the manuscript, and statistical analysis for the IDEAL trial.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?